Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hasenburg

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Annals of Surgical Oncology|February 20, 2009
Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosisP Harter, M Hahmann, H J Lueck, et al.
Geburtshilfe Und Frauenheilkunde|March 5, 2016
A Review of Integrative Medicine in Gynaecological OncologyM Kalder, T Müller, D Fischer, et al.
British Journal of Cancer|October 15, 2014
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancerJ Stephen, G Murray, D A Cameron, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2018
Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trialM G M Derks, E Bastiaannet, W van de Water, et al.
British Journal of Cancer|October 5, 2013
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trialJ M S Bartlett, C L Brookes, T Piper, et al.
The British Journal of Surgery|April 16, 2010
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countriesJ G H van Nes, C Seynaeve, S Jones, et al.
Zentralblatt Fur Gynakologie|February 2, 2006
[Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO]B Schmalfeldt, A du Bois, A Burges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2019
Gynecologic cancers in pregnancy: guidelines based on a third international consensus meetingF Amant, P Berveiller, I A Boere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2014
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT studyF Trillsch, S Mahner, L Woelber, et al.
British Journal of Cancer|January 7, 2015
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT studyF Trillsch, S Mahner, E Vettorazzi, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Annals of Surgical Oncology|February 20, 2009
Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosisP Harter, M Hahmann, H J Lueck, et al.
Geburtshilfe Und Frauenheilkunde|March 5, 2016
A Review of Integrative Medicine in Gynaecological OncologyM Kalder, T Müller, D Fischer, et al.
British Journal of Cancer|October 15, 2014
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancerJ Stephen, G Murray, D A Cameron, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2018
Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trialM G M Derks, E Bastiaannet, W van de Water, et al.
British Journal of Cancer|October 5, 2013
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trialJ M S Bartlett, C L Brookes, T Piper, et al.
The British Journal of Surgery|April 16, 2010
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countriesJ G H van Nes, C Seynaeve, S Jones, et al.
Zentralblatt Fur Gynakologie|February 2, 2006
[Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO]B Schmalfeldt, A du Bois, A Burges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2019
Gynecologic cancers in pregnancy: guidelines based on a third international consensus meetingF Amant, P Berveiller, I A Boere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2014
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT studyF Trillsch, S Mahner, L Woelber, et al.
British Journal of Cancer|January 7, 2015
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT studyF Trillsch, S Mahner, E Vettorazzi, et al.
Pageof 7